Introduction
Nicorette® Microtab is a nicotine replacement therapy (NRT) designed to help smokers reduce cravings and withdrawal symptoms when stopping or cutting down smoking.
The product delivers nicotine sublingually (under the tongue), providing nicotine without exposure to harmful combustion products from cigarettes.
It is intended to be used alongside behavioral support to improve quit success.
Key Points
Mechanism of action: Nicotine is absorbed through the lining of the mouth, relieving withdrawal symptoms without producing the rapid “buzz” associated with smoking.
Administration: Tablets must be placed under the tongue and allowed to dissolve slowly (~30 minutes); they must not be chewed or swallowed.
Dosing guidance:
≤20 cigarettes/day: 1 microtab every hour
20 cigarettes/day: 2 microtabs every hour
Typical use: 8–24 microtabs/day
Maximum dose: 40 microtabs/day
Treatment approaches: Supports both immediate cessation and gradual reduction strategies.
Duration of use:
Adults (≥18 years): up to 9 months without medical advice
Children (12–17 years): maximum 12 weeks
Safety considerations:
Nicotine is not the main cause of smoking-related disease; harm arises primarily from toxins in tobacco smoke.
Use with caution in individuals with cardiovascular disease, gastrointestinal conditions, diabetes, or seizure history.
Adverse effects: Common effects include nausea, hiccups, headache, throat irritation, and mouth discomfort; serious reactions are rare but require medical attention.
Conclusion
Nicorette® Microtab provides a controlled, non-combustible source of nicotine to support smoking cessation.
When used as directed, it effectively reduces cravings and withdrawal while avoiding exposure to toxic components of cigarette smoke.
Proper dosing, correct sublingual use, and behavioral support are essential to maximize safety and quit success.
